NCT04094285View on ClinicalTrials.gov

The Effect of Hyperoxia and Hypoxia on Fluorescence Lifetime Imaging Ophthalmoscopy in Healthy Subjects- a Randomized, Double Blind, Crossover Study

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 24, 2019

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions

To Investigate the Effect of 100% Oxygen Breathing on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Healthy Subjects

Interventions

DRUG

SAUERSTOFF

"SAUERSTOFF medizinisch, Messer GmbH, Industriestrasse 5, 2352 Gumpoldskirchen, Austria~Dose:~min. 95.5%, breathing for 30 minutes"

DRUG

STICKSTOFF

"STICKSTOFF medizinisch, Messer GmbH, Industriestrasse 5, 2352 Gumpoldskirchen, Austria~Dose:~88% with 12% oxygen, breathing for 30 minutes"

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Austria, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT04094285 - The Effect of Hyperoxia and Hypoxia on Fluorescence Lifetime Imaging Ophthalmoscopy in Healthy Subjects- a Randomized, Double Blind, Crossover Study | Biotech Hunter | Biotech Hunter